Wangbin Zhou
Stock Analyst at Citi
(3.60)
# 2,147
Out of 4,468 analysts
20
Total ratings
35.3%
Success rate
20.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Wangbin Zhou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1672 Ascletis Pharma Inc. | Reiterated: Buy | $32.00 | $11.54 | +177.30% | 2 | Feb 3, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Maintained: Buy | $105.00 → $110.00 | $87.80 | +25.28% | 2 | Aug 28, 2025 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Maintained: Buy | $560.00 | $499.00 | +12.22% | 1 | Aug 20, 2025 | |
| HKG: 0013 HUTCHMED (China) Limited | Maintained: Buy | $42.00 → $36.00 | $18.05 | +99.45% | 2 | Aug 11, 2025 | |
| HKG: 1530 3SBio Inc. | Maintained: Buy | $21.00 → $36.00 | $19.55 | +84.14% | 2 | Jul 28, 2025 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $98.00 → $185.00 | $102.40 | +80.66% | 3 | Jul 28, 2025 | |
| HKG: 1877 Shanghai Junshi Biosciences Co., Ltd. | Maintained: Buy | $32.00 | $18.83 | +69.94% | 1 | Jul 28, 2025 | |
| HKG: 6996 Antengene Corporation Limited | Downgraded: Hold | $3.50 | $4.32 | n/a | 1 | Jun 27, 2025 | |
| HKG: 9995 RemeGen Co., Ltd. | Maintained: Buy | $32.00 | $87.80 | n/a | 1 | Mar 31, 2025 | |
| LEGN Legend Biotech | Maintained: Buy | $95 | $29.91 | n/a | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25.00 → $40.00 | $27.80 | n/a | 2 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60.00 | $81.35 | n/a | 1 | Dec 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52.00 | $36.88 | n/a | 1 | Dec 5, 2024 |
Ascletis Pharma Inc.
Feb 3, 2026
Reiterated: Buy
Price Target: $32.00
Current: $11.54
Upside: +177.30%
Innovent Biologics, Inc.
Aug 28, 2025
Maintained: Buy
Price Target: $105.00 → $110.00
Current: $87.80
Upside: +25.28%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Aug 20, 2025
Maintained: Buy
Price Target: $560.00
Current: $499.00
Upside: +12.22%
HUTCHMED (China) Limited
Aug 11, 2025
Maintained: Buy
Price Target: $42.00 → $36.00
Current: $18.05
Upside: +99.45%
3SBio Inc.
Jul 28, 2025
Maintained: Buy
Price Target: $21.00 → $36.00
Current: $19.55
Upside: +84.14%
Akeso, Inc.
Jul 28, 2025
Maintained: Buy
Price Target: $98.00 → $185.00
Current: $102.40
Upside: +80.66%
Shanghai Junshi Biosciences Co., Ltd.
Jul 28, 2025
Maintained: Buy
Price Target: $32.00
Current: $18.83
Upside: +69.94%
Antengene Corporation Limited
Jun 27, 2025
Downgraded: Hold
Price Target: $3.50
Current: $4.32
Upside: n/a
RemeGen Co., Ltd.
Mar 31, 2025
Maintained: Buy
Price Target: $32.00
Current: $87.80
Upside: n/a
Legend Biotech
Mar 12, 2025
Maintained: Buy
Price Target: $95
Current: $29.91
Upside: n/a
Jan 15, 2025
Maintained: Hold
Price Target: $25.00 → $40.00
Current: $27.80
Upside: n/a
Dec 30, 2024
Maintained: Buy
Price Target: $60.00
Current: $81.35
Upside: n/a
Dec 5, 2024
Maintained: Buy
Price Target: $52.00
Current: $36.88
Upside: n/a